GRFS
Grifols SA ADR
NASDAQ: GRFS · HEALTHCARE · DRUG MANUFACTURERS - GENERAL
$8.12
+0.25% today
Updated 2026-10-28
Market cap
$5.20B
P/E ratio
9.92
P/S ratio
0.70x
EPS (TTM)
$0.77
Dividend yield
—
52W range
$7 – $10
Volume
0.6M
Grifols SA ADR (GRFS) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$8.12
12-Month target
$9.35
2030 Target
—
Intrinsic (DCF)
$30.89
Financial forecast
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $4.9B | $6.1B | $6.6B | $7.2B | $7.2B |
| EPS | — | — | — | — | — |
CAGR applied: — (capped 20%) · P/E: 9.92x (capped 25x) · Margin: 6.09%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.